379 related articles for article (PubMed ID: 19065723)
1. The risk of gastric cancer in patients with duodenal and gastric ulcer: research progresses and clinical implications.
Zhang Z
J Gastrointest Cancer; 2007; 38(1):38-45. PubMed ID: 19065723
[TBL] [Abstract][Full Text] [Related]
2. Role of Helicobacter pylori infection and nonsteroidal anti-inflammatory drug use in bleeding peptic ulcers in Japan.
Ootani H; Iwakiri R; Shimoda R; Nakahara S; Amemori S; Fujise T; Kikkawa A; Tsunada S; Sakata H; Fujimoto K
J Gastroenterol; 2006 Jan; 41(1):41-6. PubMed ID: 16501856
[TBL] [Abstract][Full Text] [Related]
3. Ulcer site and complications: relation to Helicobacter pylori infection and NSAID use.
al-Assi MT; Genta RM; Karttunen TJ; Graham DY
Endoscopy; 1996 Feb; 28(2):229-33. PubMed ID: 8739738
[TBL] [Abstract][Full Text] [Related]
4. The risk of stomach cancer in patients with gastric or duodenal ulcer disease.
Hansson LE; Nyrén O; Hsing AW; Bergström R; Josefsson S; Chow WH; Fraumeni JF; Adami HO
N Engl J Med; 1996 Jul; 335(4):242-9. PubMed ID: 8657240
[TBL] [Abstract][Full Text] [Related]
5. Role of Helicobacter pylori in ulcer healing and recurrence of gastric and duodenal ulcers in longterm NSAID users. Response to omeprazole dual therapy.
Bianchi Porro G; Parente F; Imbesi V; Montrone F; Caruso I
Gut; 1996 Jul; 39(1):22-6. PubMed ID: 8881802
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori, non-steroidal anti-inflammatory drugs and smoking in risk pattern of gastroduodenal ulcers.
Konturek SJ; Bielański W; Płonka M; Pawlik T; Pepera J; Konturek PC; Czarnecki J; Penar A; Jedrychowski W
Scand J Gastroenterol; 2003 Sep; 38(9):923-30. PubMed ID: 14531527
[TBL] [Abstract][Full Text] [Related]
7. Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong.
Xia B; Xia HH; Ma CW; Wong KW; Fung FM; Hui CK; Chan CK; Chan AO; Lai KC; Yuen MF; Wong BC
Aliment Pharmacol Ther; 2005 Aug; 22(3):243-9. PubMed ID: 16091062
[TBL] [Abstract][Full Text] [Related]
8. [The risk of stomach cancer in gastric or duodenal ulcer: does it support or exclude the Helicobacter pylori theory?].
Fischbach W
Z Gastroenterol; 1998 Jun; 36(6):535-7. PubMed ID: 9675839
[No Abstract] [Full Text] [Related]
9. What consideration should be given to Helicobacter pylori in treating nonsteroidal anti-inflammatory drug ulcers?
Hawkey CJ
Eur J Gastroenterol Hepatol; 2000 Jun; 12 Suppl 1():S17-20. PubMed ID: 10929894
[TBL] [Abstract][Full Text] [Related]
10. Interaction of Helicobacter pylori infection and nonsteroidal anti-inflammatory drugs in gastric and duodenal ulcers.
Venerito M; Malfertheiner P
Helicobacter; 2010 Aug; 15(4):239-50. PubMed ID: 20633184
[TBL] [Abstract][Full Text] [Related]
11. How do NSAIDs cause ulcer disease?
Wallace JL
Baillieres Best Pract Res Clin Gastroenterol; 2000 Feb; 14(1):147-59. PubMed ID: 10749095
[TBL] [Abstract][Full Text] [Related]
12. Helicobacter pylori and bleeding duodenal ulcer: prevalence of the infection and role of non-steroidal anti-inflammatory drugs.
Gisbert JP; Gonzalez L; de Pedro A; Valbuena M; Prieto B; Llorca I; Briz R; Khorrami S; Garcia-Gravalos R; Pajares JM
Scand J Gastroenterol; 2001 Jul; 36(7):717-24. PubMed ID: 11444470
[TBL] [Abstract][Full Text] [Related]
13. Helicobacter pylori infection is a protective factor for bleeding gastric ulcers but not for bleeding duodenal ulcers in NSAID users.
Santolaria S; Lanas A; Benito R; Pérez-Aisa Mf; Montoro M; Sainz R
Aliment Pharmacol Ther; 1999 Nov; 13(11):1511-8. PubMed ID: 10571609
[TBL] [Abstract][Full Text] [Related]
14. Clinical science of Helicobacter pylori infection: ulcers and NSAIDs.
Calam J
Br Med Bull; 1998; 54(1):55-62. PubMed ID: 9604430
[TBL] [Abstract][Full Text] [Related]
15. Ulcer-healing drugs are required after eradication of Helicobacter pylori in patients with gastric ulcer but not duodenal ulcer haemorrhage.
Lai KC; Hui WM; Wong BC; Hu WH; Lam SK
Aliment Pharmacol Ther; 2000 Aug; 14(8):1071-6. PubMed ID: 10930902
[TBL] [Abstract][Full Text] [Related]
16. How does Helicobacter pylori infection interact with non-steroidal anti-inflammatory drugs?
Chan FK; Sung JJ
Baillieres Best Pract Res Clin Gastroenterol; 2000 Feb; 14(1):161-72. PubMed ID: 10749096
[TBL] [Abstract][Full Text] [Related]
17. Influence of sex and Helicobacter pylori on development and healing of gastroduodenal lesions in non-steroidal anti-inflammatory drug users.
Hawkey CJ; Wilson I; Naesdal J; Långström G; Swannell AJ; Yeomans ND
Gut; 2002 Sep; 51(3):344-50. PubMed ID: 12171954
[TBL] [Abstract][Full Text] [Related]
18. Ulcer bleeding and perforation: non-steroidal anti-inflammatory drugs or Helicobacter pylori.
Svanes C; Ovrebø K; Søreide O
Scand J Gastroenterol Suppl; 1996; 220():128-31. PubMed ID: 8898450
[TBL] [Abstract][Full Text] [Related]
19. Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers.
Chan FK; Sung JJ; Chung SC; To KF; Yung MY; Leung VK; Lee YT; Chan CS; Li EK; Woo J
Lancet; 1997 Oct; 350(9083):975-9. PubMed ID: 9329511
[TBL] [Abstract][Full Text] [Related]
20. Demographic and endoscopic characteristics of patients with Helicobacter pylori positive and negative peptic ulcer disease.
Xia HH; Phung N; Kalantar JS; Talley NJ
Med J Aust; 2000 Nov; 173(10):515-9. PubMed ID: 11194733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
